VanEck Associates’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
84,337
-1,581
| -2% | -$27K | ﹤0.01% | 999 |
|
|
2025
Q1 | $5.48M | Buy |
85,918
+1,084
| +1% | +$69.2K | 0.01% | 676 |
|
|
2024
Q4 | $10.3M | Buy |
84,834
+16,658
| +24% | +$2.03M | 0.01% | 457 |
|
|
2024
Q3 | $8.85M | Sell |
68,176
-14,930
| -18% | -$1.94M | 0.01% | 483 |
|
|
2024
Q2 | $13.1M | Sell |
83,106
-3,223
| -4% | -$509K | 0.02% | 358 |
|
|
2024
Q1 | $11.2M | Buy |
86,329
+4,374
| +5% | +$566K | 0.02% | 377 |
|
|
2023
Q4 | $7.9M | Sell |
81,955
-14,510
| -15% | -$1.4M | 0.01% | 436 |
|
|
2023
Q3 | $11.7M | Sell |
96,465
-326
| -0.3% | -$39.5K | 0.03% | 319 |
|
|
2023
Q2 | $11.1M | Buy |
96,791
+4,357
| +5% | +$499K | 0.02% | 335 |
|
|
2023
Q1 | $12.7M | Buy |
92,434
+90,800
| +5,557% | +$12.5M | 0.03% | 305 |
|
|
2022
Q4 | $212K | Buy |
1,634
+480
| +42% | +$62.3K | ﹤0.01% | 1083 |
|
|
2022
Q3 | $128K | Buy |
+1,154
| New | +$128K | ﹤0.01% | 1135 |
|
|
2021
Q2 | – | Sell |
-26,209
| Closed | -$1.95M | – | 1309 |
|
|
2021
Q1 | $1.95M | Sell |
26,209
-70,126
| -73% | -$5.23M | 0.01% | 616 |
|
|
2020
Q4 | $16.4M | Buy |
96,335
+2,439
| +3% | +$416K | 0.05% | 229 |
|
|
2020
Q3 | $13.2M | Sell |
93,896
-12,268
| -12% | -$1.72M | 0.04% | 225 |
|
|
2020
Q2 | $17M | Buy |
106,164
+29,230
| +38% | +$4.69M | 0.06% | 196 |
|
|
2020
Q1 | $7.53M | Sell |
76,934
-23,104
| -23% | -$2.26M | 0.04% | 258 |
|
|
2019
Q4 | $12.9M | Sell |
100,038
-1,314
| -1% | -$170K | 0.05% | 225 |
|
|
2019
Q3 | $7.63M | Buy |
101,352
+4,912
| +5% | +$370K | 0.04% | 259 |
|
|
2019
Q2 | $14.7M | Sell |
96,440
-28,795
| -23% | -$4.38M | 0.07% | 189 |
|
|
2019
Q1 | $14.9M | Buy |
125,235
+910
| +0.7% | +$108K | 0.07% | 186 |
|
|
2018
Q4 | $13.6M | Buy |
124,325
+15,763
| +15% | +$1.72M | 0.07% | 202 |
|
|
2018
Q3 | $17.5M | Buy |
+108,562
| New | +$17.5M | 0.09% | 193 |
|